Literature DB >> 23603476

Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.

H Randhawa1, K Kibble, H Zeng, M P Moyer, K M Reindl.   

Abstract

Piperlongumine (PPLGM) is a bioactive compound isolated from long peppers that shows selective toxicity towards a variety of cancer cell types including colon cancer. The signaling pathways that lead to cancer cell death in response to PPLGM exposure have not been previously identified. Our objective was to identify the intracellular signaling mechanisms by which PPLGM leads to enhanced colon cancer cell death. We found that PPLGM inhibited the growth of colon cancer cells in time- and concentration-dependent manners, but was not toxic toward normal colon mucosal cells at concentrations below 10 μM. Acute (0-60 min) and prolonged (24h) exposure of HT-29 cells to PPLGM resulted in phosphorylation of ERK. To investigate whether ERK signaling was involved in PPLGM-mediated cell death, we treated HT-29 cells with the MEK inhibitor U0126, prior to treating with PPLGM. We found that U0126 attenuated PPLGM-induced activation of ERK and partially protected against PPLGM-induced cell death. These results suggest that PPLGM works, at least in part, through the MEK/ERK pathway to result in colon cancer cell death. A more thorough understanding of the molecular mechanisms by which PPLGM induces colon cancer cell death will be useful in developing therapeutic strategies to treat colon cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell signaling; Colon cancer; ERK; MAPK; MEK; MEK/ERK; PPLGM; Piperlongumine; RAS; ROS; extracellular-signal-regulated kinase; mitogen-activated protein kinase; piperlongumine; rat sarcoma oncogene; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 23603476      PMCID: PMC3749270          DOI: 10.1016/j.tiv.2013.04.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  42 in total

1.  Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells.

Authors:  Allison A Ellington; Mark A Berhow; Keith W Singletary
Journal:  Carcinogenesis       Date:  2005-08-19       Impact factor: 4.944

2.  In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper.

Authors:  D P Bezerra; F O Castro; A P N N Alves; C Pessoa; M O Moraes; E R Silveira; M A S Lima; F J M Elmiro; L V Costa-Lotufo
Journal:  Braz J Med Biol Res       Date:  2006-06-02       Impact factor: 2.590

Review 3.  ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence.

Authors:  Sebastien Cagnol; Jean-Claude Chambard
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

4.  Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer.

Authors:  Patrick Naumann; Franco Fortunato; Hanswalter Zentgraf; Markus W Büchler; Ingrid Herr; Jens Werner
Journal:  Int J Oncol       Date:  2011-04-29       Impact factor: 5.650

5.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

Review 6.  Micronutrients in cancer chemoprevention.

Authors:  Peter Greenwald; John A Milner; Darrell E Anderson; Sharon S McDonald
Journal:  Cancer Metastasis Rev       Date:  2002       Impact factor: 9.264

Review 7.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

8.  ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.

Authors:  Jiahao Liu; Weike Mao; Bo Ding; Chang-seng Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-05       Impact factor: 4.733

Review 9.  Reactive oxygen species in oncogenic transformation.

Authors:  L Behrend; G Henderson; R M Zwacka
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

10.  Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.

Authors:  Jun Soo Bang; Da Hee Oh; Hyun Mi Choi; Bong-Jun Sur; Sung-Jig Lim; Jung Yeon Kim; Hyung-In Yang; Myung Chul Yoo; Dae-Hyun Hahm; Kyoung Soo Kim
Journal:  Arthritis Res Ther       Date:  2009-03-30       Impact factor: 5.156

View more
  35 in total

1.  Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine.

Authors:  Wayne Harshbarger; Sudershan Gondi; Scott B Ficarro; John Hunter; Durga Udayakumar; Deepak Gurbani; William D Singer; Yan Liu; Lianbo Li; Jarrod A Marto; Kenneth D Westover
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

2.  JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells.

Authors:  Wen Li; Chuangyu Wen; Haiyan Bai; Xiaoyan Wang; Xiaoli Zhang; Lanlan Huang; Xiangling Yang; Aikichi Iwamoto; Huanliang Liu
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

3.  Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome.

Authors:  Angel Y F Kam; Sadhna O Piryani; Chad M McCall; Hee Su Park; David A Rizzieri; Phuong L Doan
Journal:  Clin Cancer Res       Date:  2019-04-05       Impact factor: 12.531

4.  JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells.

Authors:  Jiyan Mohammad; Rahul R Singh; Cody Riggle; Brandon Haugrud; Maher Y Abdalla; Katie M Reindl
Journal:  Apoptosis       Date:  2019-10       Impact factor: 4.677

5.  Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.

Authors:  Xin-xin Xiong; Ju-mei Liu; Xin-yao Qiu; Feng Pan; Shang-bin Yu; Xiao-qian Chen
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

6.  Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.

Authors:  Nikee Awasthee; Anusmita Shekher; Vipin Rai; Sumit S Verma; Shruti Mishra; Anupam Dhasmana; Subash C Gupta
Journal:  Apoptosis       Date:  2022-02-04       Impact factor: 4.677

7.  Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Authors:  Yin-Ju Chen; Chia-Chun Kuo; Lai-Lei Ting; Long-Sheng Lu; Ya-Ching Lu; Ann-Joy Cheng; Yun-Tien Lin; Chien-Ho Chen; Jo-Ting Tsai; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

8.  Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathways.

Authors:  Harsharan Dhillon; Sujan Mamidi; Phillip McClean; Katie M Reindl
Journal:  J Med Food       Date:  2016-04-27       Impact factor: 2.786

9.  EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer.

Authors:  Wen-Hui Weng; Wai-Hung Leung; Yeu Jye Pang; Li-Wei Kuo; Hsi-Hsien Hsu
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

10.  Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.

Authors:  Yong Chen; Ju Mei Liu; Xin Xin Xiong; Xin Yao Qiu; Feng Pan; Di Liu; Shu Jue Lan; Si Jin; Shang Bin Yu; Xiao Qian Chen
Journal:  Oncotarget       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.